Alembic PharmaceuticalsAPLLTD 
$12.52-1.60%24h
-1.60%24h
Global rank4577
Market cap$2.46B
Change 7d-6.54%
YTD Performance38.14%
SP500 benchmarkOutperform
P/E0.72
P/S3.75
Revenue$655.59M
Earnings$40.77M
Dividend yield-
Main Sector
Healthcare
Alembic Pharmaceuticals (APLLTD) Net Assets
APLLTD Net Assets in 2023: $43.70B
As of 30 Aug 2024, Alembic Pharmaceuticals net assets is $43.70B, an decrease of -16.56% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Alembic Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Alembic Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
APLLTD Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $43.70B | -16.56% |
| 2022 | $52.38B | 3.37% |
| 2021 | $50.67B | 58.82% |
| 2020 | $31.90B | 140.87% |
| 2019 | $13.25B | - |
View the Top Net Assets Companies
